2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …

E Arbelo, A Protonotarios, JR Gimeno… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The diagnosis and evaluation of dilated cardiomyopathy

AG Japp, A Gulati, SA Cook, MR Cowie… - Journal of the American …, 2016 - jacc.org
Dilated cardiomyopathy (DCM) is best understood as the final common response of
myocardium to diverse genetic and environmental insults. A rigorous work-up can exclude …

[HTML][HTML] Хроническая сердечная недостаточность. Клинические рекомендации 2020

СН Терещенко, АС Галявич, ТМ Ускач… - Российский …, 2020 - cyberleninka.ru
КТИ—кардиоторакальный индекс КШ—коронарное шунтирование ЛЖ—левый
желудочек МНО—международное нормализованное отношение МРТ—магнитно …

Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy

AR Patel, CM Kramer - JACC: Cardiovascular Imaging, 2017 - jacc.org
Cardiac magnetic resonance (CMR) is a valuable tool for the evaluation of patients with, or
at risk for, heart failure and has a growing impact on diagnosis, clinical management, and …

Imaging, biomarker, and clinical predictors of cardiac remodeling in heart failure with reduced ejection fraction

A Aimo, HK Gaggin, A Barison, M Emdin, JL Januzzi - JACC: Heart Failure, 2019 - jacc.org
In response to injury, hemodynamic changes, or neurohormonal activation, the heart
undergoes a series of structural and functional changes that have been termed cardiac …

[HTML][HTML] Current understanding of the pathophysiology of myocardial fibrosis and its quantitative assessment in heart failure

T Liu, D Song, J Dong, P Zhu, J Liu, W Liu, X Ma… - Frontiers in …, 2017 - frontiersin.org
Myocardial fibrosis is an important part of cardiac remodeling that leads to heart failure and
death. Myocardial fibrosis results from increased myofibroblast activity and excessive …

Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy

SJ Buss, K Breuninger, S Lehrke, A Voss… - European Heart …, 2015 - academic.oup.com
Aims To investigate the prognostic impact of left-ventricular (LV) cardiac magnetic
resonance (CMR) deformation imaging in patients with non-ischaemic dilated …

T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy

F aus dem Siepen, SJ Buss… - European Heart …, 2015 - academic.oup.com
Aim The aim of this study was to determine the value of extracellular volume fraction (ECV)
for the non-invasive assessment of diffuse myocardial fibrosis (MF) in different stages of …

From left ventricular hypertrophy to dysfunction and failure

D Lazzeroni, O Rimoldi, PG Camici - Circulation Journal, 2016 - jstage.jst.go.jp
Left ventricular hypertrophy (LVH) is growth in left ventricular mass caused by increased
cardiomyocyte size. LVH can be a physiological adaptation to strenuous physical exercise …

Native T1 and extracellular volume measurements by cardiac MRI in healthy adults: a meta-analysis

M Gottbrecht, CM Kramer, M Salerno - Radiology, 2019 - pubs.rsna.org
Purpose To summarize the literature by performing a systematic review and pooled analysis
of the data, to understand the extent of variability among studies of native T1 and …